default author photo

Haohua Zhu

Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs

SCHOLARLY PAPERS

2

DOWNLOADS

90

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

The Feasibility of Using Biomarkers Derived from Circulating Tumor DNA Sequencing as Predictive Classifiers in Patients with Small-Cell Lung Cancer

Number of pages: 42 Posted: 01 Jun 2021
Yu Feng, Yutao Liu, Mingming Yuan, Guilan Dong, Hongxia Zhang, Tongmei Zhang, Lianpeng Chang, Xuefeng Xia, Lifeng Li, Haohua Zhu, Puyuan Xing, Hongyu Wang, Yuankai Shi, Zhijie Wang and Xingsheng Hu
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Medical Oncology, Chinese Academy of Medical Sciences - State Key Lab of Molecular Oncology, Geneplus-Beijing Co. Ltd. - Medical Center, Geneplus-Beijing Co. Ltd. - Medical Center, Capital Medical University - Department of Respiratory and Critical Care Medicine, Capital Medical University - Beijing Tuberculosis and Thoracic Tumor Research Institute, Geneplus-Beijing Co. Ltd., Geneplus-Beijing Institute, Geneplus-Beijing Institute, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Molecular Oncology and Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs
Downloads 63 (933,592)

Abstract:

Loading...

Small-cell lung cancer; Molecular tumor burden index; Circulating tumor DNA sequencing; Progression-free survival; Predictive classifiers

2.

Efficacy and safety of furmonertinib plus anlotinib as first-line treatment for locally advanced or metastatic NSCLC patients: a single-arm, phase I/II trial

Number of pages: 33 Posted: 08 Sep 2025
Huiyang Shi, Haohua Zhu, Le Tang, Jingyu Lu, Kai Zhu, Miaohan Wang, Xingsheng Hu and Yuankai Shi
affiliation not provided to SSRN, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs
Downloads 27 (1,359,097)

Abstract:

Loading...

Furmonertinib, Anlotinib, First-line treatment, NSCLC, Epidermal growth factor receptor